0

Liver Disease Collection
 61-80 of 973 Articles
Articles |  17 January 2006
Brief Communication: Tamoxifen Therapy for Nonmalignant Retroperitoneal Fibrosis
Eric F.H. van Bommel, MD, PhD; Tadek R. Hendriksz, MD; Antonius W.L.C. Huiskes, MD; et al.
Ann Intern Med. 2006;144(2):101-106. doi:10.7326/0003-4819-144-2-200601170-00007
Articles |  15 November 2005
The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
Masahide Hamaguchi, MD; Takao Kojima, MD; Noriyuki Takeda, MD; et al.
Ann Intern Med. 2005;143(10):722-728. doi:10.7326/0003-4819-143-10-200511150-00009
Editorials |  15 November 2005
Dangerous Liaisons: The Metabolic Syndrome and Nonalcoholic Fatty Liver Disease
Elizabeth E. Powell, MBBS, PhD; Julie R. Jonsson, BSc, PhD; Andrew D. Clouston, MBBS, PhD
Ann Intern Med. 2005;143(10):753-754. doi:10.7326/0003-4819-143-10-200511150-00015
Current Clinical Issues |  21 June 2005
Liver Cancer on the Rise
Jennifer Fisher Wilson
Ann Intern Med. 2005;142(12_Part_1):1029-1032. doi:10.7326/0003-4819-142-12_Part_1-200506210-00024
Articles |  17 May 2005
Treatment Alternatives for Chronic Hepatitis B Virus Infection: A Cost-Effectiveness Analysis
Fasiha Kanwal, MD, MSHS; Ian M. Gralnek, MD, MSHS; Paul Martin, MD; et al.
Ann Intern Med. 2005;142(10):821-831. doi:10.7326/0003-4819-142-10-200505170-00007
Reviews |  15 March 2005
Recommendations for the Diagnosis and Treatment of the Acute Porphyrias
Karl E. Anderson, MD; Joseph R. Bloomer, MD; Herbert L. Bonkovsky, MD; et al.
Ann Intern Med. 2005;142(6):439-450. doi:10.7326/0003-4819-142-6-200503150-00010
Articles |  15 February 2005
A Randomized, Controlled Trial of Combination Therapy for Chronic Hepatitis B: Comparing Pegylated Interferon-α2b and Lamivudine with Lamivudine Alone
Henry Lik-Yuen Chan, MD; Nancy Wai-Yee Leung, MD; Alex Yui Hui, MB, BChir; et al.
Ann Intern Med. 2005;142(4):240-250. doi:10.7326/0003-4819-142-4-200502150-00006
Articles |  2 March 2004
Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C: A Randomized Study of Treatment Duration and Ribavirin Dose
Stephanos J. Hadziyannis, MD; Hoel Sette, MD; Timothy R. Morgan, MD; et al.
Ann Intern Med. 2004;140(5):346-355. doi:10.7326/0003-4819-140-5-200403020-00010
Reviews |  2 March 2004
Heterogeneous Virologic Response Rates to Interferon-Based Therapy in Patients with Chronic Hepatitis C: Who Responds Less Well?
Stefan Zeuzem, MD
Ann Intern Med. 2004;140(5):370-381. doi:10.7326/0003-4819-140-8-200404200-00009
Articles |  18 November 2003 FREE
The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update
Hashem B. El-Serag, MD, MPH; Jessica A. Davila, PhD; Nancy J. Petersen, PhD; et al.
Ann Intern Med. 2003;139(10):817-823. doi:10.7326/0003-4819-139-10-200311180-00009
Reviews |  21 October 2003
Delayed Drug Hypersensitivity Reactions
Werner J. Pichler, MD
Ann Intern Med. 2003;139(8):683-693. doi:10.7326/0003-4819-139-8-200310210-00012
Brief Communications |  16 September 2003
Hepatic Injury in 12 Patients Taking the Herbal Weight Loss Aids Chaso or Onshido
Masayuki Adachi, MD; Hidetsugu Saito, MD, PhD; Hisashi Kobayashi, MD; et al.
Ann Intern Med. 2003;139(6):488-492. doi:10.7326/0003-4819-139-6-200309160-00012
Articles |  5 August 2003
The Effect of Selective Intestinal Decontamination on the Hyperdynamic Circulatory State in Cirrhosis: A Randomized Trial
Brindhesha Rasaratnam , MBBS, FRACP; David Kaye , MBBS, FRACP, PhD; Garry Jennings , MBBS, FRACP, MD; et al.
Ann Intern Med. 2003;139(3):186-193. doi:10.7326/0003-4819-139-3-200308050-00008
Reviews |  1 July 2003 FREE
Test Characteristics of α-Fetoprotein for Detecting Hepatocellular Carcinoma in Patients with Hepatitis C: A Systematic Review and Critical Analysis
Samir Gupta, MD; Stephen Bent, MD; Jeffrey Kohlwes, MD, MPH
Ann Intern Med. 2003;139(1):46-50. doi:10.7326/0003-4819-139-1-200307010-00012
Articles |  15 April 2003
Serum Ferritin Level Predicts Advanced Hepatic Fibrosis among U.S. Patients with Phenotypic Hemochromatosis
Elizabeth D. Morrison, MD; David J. Brandhagen, MD; Pradyumna D. Phatak, MD; et al.
Ann Intern Med. 2003;138(8):627-633. doi:10.7326/0003-4819-138-8-200304150-00008
Articles |  18 February 2003
Interferon Therapy after Tumor Ablation Improves Prognosis in Patients with Hepatocellular Carcinoma Associated with Hepatitis C Virus
Yasushi Shiratori, MD; Shuichiro Shiina, MD; Takuma Teratani, MD; et al.
Ann Intern Med. 2003;138(4):299-306. doi:10.7326/0003-4819-138-4-200302180-00008
Brief Communications |  4 February 2003
Treatment of Chronic Hepatitis C in a State Correctional Facility
Scott A. Allen, MD; Anne C. Spaulding, MD; Albert M. Osei, MD; et al.
Ann Intern Med. 2003;138(3):187-190. doi:10.7326/0003-4819-138-3-200302040-00010
Editorials |  4 February 2003
Adopting More Systematic Approaches to Hepatitis C Treatment in Correctional Facilities
Theodore M. Hammett, PhD
Ann Intern Med. 2003;138(3):235-236. doi:10.7326/0003-4819-138-3-200302040-00021
Articles |  17 December 2002
Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States
George Ostapowicz, MD; Robert J. Fontana, MD; Frank V. Schiødt, MD; et al.
Ann Intern Med. 2002;137(12):947-954. doi:10.7326/0003-4819-137-12-200212170-00007
Brief Communications |  17 December 2002
Prevalence of Liver Disease in a Population of Asymptomatic Persons with Hepatitis C Virus Infection
Alfredo Alberti, MD; Franco Noventa, MD; Luisa Benvegnù, MD; et al.
Ann Intern Med. 2002;137(12):961-964. doi:10.7326/0003-4819-137-12-200212170-00009
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)